Infection Clinical Trials

1,468 recruitingLast updated: June 13, 2026

There are 1,468 actively recruiting infection clinical trials across 122 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1. Top locations include New York, New York, United States, Houston, Texas, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Infection Trials at a Glance

1,468 actively recruiting trials for infection are listed on ClinicalTrialsFinder across 6 cities in 122 countries. The largest study group is Not Applicable with 422 trials, with the heaviest enrollment activity in New York, Houston, and Boston. Lead sponsors running infection studies include National Institute of Allergy and Infectious Diseases (NIAID), Assistance Publique - Hôpitaux de Paris, and University Hospital, Strasbourg, France.

Treatments under study

About Infection Clinical Trials

Looking for clinical trials for Infection? There are currently 61 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 1,468 trials

Recruiting
Phase 1

Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.

InfluenzaAcute Respiratory Viral Infections
Valenta Pharm JSC36 enrolled1 locationNCT07645534
Recruiting

Impacts of HIV Treatment Regimens on Archived Drug Resistance

HIV-1-infectionAntiretroviral TherapyDrug Resistance, Microbial
Chinese University of Hong Kong420 enrolled1 locationNCT07643948
Recruiting

Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)

Urinary Tract InfectionsAntiobiotic StewardshipEmerging Infectious Disease
Centre Hospitalier Intercommunal Creteil330 enrolled3 locationsNCT07559318
Recruiting
Phase 2

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Merkel Cell CarcinomaMalignant NeoplasmAcquired Immunodeficiency Syndrome+5 more
M.D. Anderson Cancer Center100 enrolled1 locationNCT02479698
Recruiting
Phase 1

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Viral Infection
Baylor College of Medicine47 enrolled2 locationsNCT04013802
Recruiting

Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study

Human Immunodeficiency Virus (HIV) -1 infectionHIV-1 Subtype A6 InfectionHIV-1 Subtype B Infection+1 more
Pomeranian Medical University Szczecin250 enrolled7 locationsNCT07370649
Recruiting
Not Applicable

Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival

Peripheral Intravenous Vein Catheter PhlebitisIntravenous Infection
Corewell Health East360 enrolled1 locationNCT06107361
Recruiting
Phase 4

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

HIV-1-infection
Gilead Sciences350 enrolled15 locationsNCT06337032
Recruiting
Phase 3

STI Testing to Enhance PrEP Use in Pregnancy

PregnancySexually Transmitted Infections (STIs)PrEP Adherence
Botswana Harvard AIDS Institute Partnership600 enrolled1 locationNCT06919614
Recruiting
Phase 2

A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With Respiratory Viruses

Respiratory Viral Infection
SynAct Pharma Aps96 enrolled11 locationsNCT07633288
Recruiting
Phase 1

R-MVST Cells for Treatment of Viral Infections

Epstein-Barr Virus InfectionsCytomegalovirus InfectionsBK Virus Infection+1 more
Columbia University36 enrolled1 locationNCT05183490
Recruiting
Phase 1Phase 2

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID)36 enrolled12 locationsNCT06071767
Recruiting
Not Applicable

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

HIV InfectionsSubstance Use Disorders
Medical University of South Carolina50 enrolled1 locationNCT05816083
Recruiting
Phase 1Phase 2

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Systemic Inflammatory Response SyndromeSARS CoV-2Respiratory distress syndrome+2 more
PEACHES BIOTECH50 enrolled3 locationsNCT06684379
Recruiting
Phase 4

Trial of an AI-enabled Digital Stethoscope to Improve Antibiotic Stewardship

Respiratory Infections in Children
Johns Hopkins University2,500 enrolled1 locationNCT07362433
Recruiting
Phase 3

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Kidney Transplant Failure and RejectionBK ViremiaKidney Transplant Infection
The University of Queensland280 enrolled13 locationsNCT05325008
Recruiting

Evaluation of Patients With HAM/TSP

HTLV-I InfectionTropical Spastic Paraparesis
National Institute of Neurological Disorders and Stroke (NINDS)750 enrolled1 locationNCT00001778
Recruiting
Phase 3

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

COVID-19 (SARS-CoV-2) infection
Pfizer2,330 enrolled244 locationsNCT06679140
Recruiting
Phase 2Phase 3

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC570 enrolled56 locationsNCT07266831
Recruiting

Study of Mycobacterial Infections

Mycobacterium Infections
National Institute of Allergy and Infectious Diseases (NIAID)1,000 enrolled1 locationNCT00018044